Skip to main content
. 2024 Jun 12;13(6):709. doi: 10.3390/antiox13060709
BBB Blood–brain barrier
BD Bipolar disorder
B-GOS Galacto-oligosaccharide
CHR Clinical high risk
CNS Central nervous system
CRP C-Reactive protein
CSF Cerebrospinal fluid
DAT Dopamine transporter
DISC Disrupted-in-schizophrenia 1
DSM-5-TR Diagnostic and Statistical Manual of Mental Disorders, 5th edition, Text Revision
FEP First-episode psychosis
FES First-episode schizophrenia
GAT GABA transporter
GABA γ-Aminobutyric acid
GBA Gut–brain axis
GF Germ-free
GI Gastrointestinal
HPA Axis Hypothalamic–pituitary–adrenal axis
5-HT 5-Hydroxytryptamine, Serotonin
INF Interferon
IL Interleukin
IP3 Inositol 1,4,5-triphosphate
LSD Lysergic acid diethylamide
LPS Lipopolysaccharide
MIA Maternal immune activation
MK-801 Dizocilpine
α-MSH α-Melanocyte-stimulating hormone
NAC N-Acetylcysteine
NMDA N-Methyl-D-aspartate
NMDAR N-Methyl-D-aspartate glutamate receptor
PVIs Parvalbumin interneurons
PCP Phencyclidine
PET Positron emission tomography
PFC Prefrontal cortex
RNS Reactive nitrogen species
ROS Reactive oxygen species
SCFA Short chain fatty acid
TGF-β1 Transforming growth factor-β1
TNF Tumor necrosis factor
VTA Ventral tegmental area